In these policy briefs, TB Europe Coalition (TBEC), the Regional Expert Group on Migration and Health in Eastern Europe and Central Asia (REG), and the HIV Policy Lab explore migrants’ access to HIV services in the Russian Federation, Armenia, and Uzbekistan, focusing on the migrants’ experience accessing care in receiving (i.e., destination) countries, including the law and policy barriers they encounter, as well as the national policy agenda in sending countries. These reviews and regional roundtable policy discussions hosted by TBEC and REG have informed a set of policy recommendations, including creating transborder agreements between sending and receiving countries to facilitate migrants’ access to HIV and TB treatment.Read more
On March 10, the HIV Policy Lab and Kaiser Family Foundation (KFF) held a virtual event sharing new analyses on the current state of HIV policies around the world and policy change opportunities and challenges on the horizon. The event shared findings from the HIV Policy Lab’s new annual Global HIV Policy Report as well as a new analysis by KFF using HIV Policy Lab data.Read more
Despite rapid scientific advances the world failed to achieve the global HIV goals set for 2020 and is not on track to reach the goal to end AIDS as a public health threat by 2030. This can be explained, at least in part, by the significant gap that remains between science on the one hand, and law and policy on the other. The HIV Policy Lab’s annual report presents the state of HIV policy across 194 countries for key HIV-related laws and policies. With not one country in the world having fully aligned its laws and policies with those recommended, significant change is still needed.Read more
An analysis of HIVPL data by the Kaiser Family Foundation finds that PEPFAR countries have stronger policy alignment with international standards than other LMICs.
Read the analysis at the Kaiser Family Foundation site.
On 8 December 2021, the Fight AIDS Coalition (FAC) held a workshop on advocacy to reduce AIDS deaths. We have the tools to prevent AIDS deaths, but people continue to die of AIDS. We need to confront the policy gaps, lack of access to life-saving tools and services, and the invisibility around AIDS deaths. Specifically, we need to increase accountability and attention for the number 1 and 2 drivers of deaths among people living with HIV (PLHIV): tuberculosis and cryptococcal meningitis. The workshop was organized by the HIV Policy Lab team, GNP+, Health GAP, ITPC, MSF, TAC, and TAG.Read more
Together with the other members of the Fight AIDS Coalition, the HIVPL team organized an open letter calling on UNITAID to continue its support for introducing life-saving AIDS/AHD services and include short-course TB treatment in its 2022-2026 investment and strategic plans. The letter was signed by 76 organizations.Read more
Together with the other members of the Fight AIDS Coalition, the HIVPL team organized an open letter to WHO emphasizing the need for greater action and attention towards AHD/AIDS-specific deaths and interventions to address the main drivers of HIV deaths: cryptococcal meningitis and tuberculosis. FAC calls for the WHO to endorse a roadmap from experts on how to reduce deaths due to cryptococcal meningitis, and fill the gaps in knowledge about the disease by measuring and reporting on cryptococcal meningitis incidence, treatment coverage, and deaths.Read more
The HIVPL team organized an open letter to PEPFAR, urging it to include reducing AIDS and AIDS deaths as an objective in its new PEPFAR Strategy: Vision 2025 and to include specific goals to address Advanced HIV Disease (AHD)/AIDS and the leading killers of PLHIV—cryptococcal meningitis and tuberculosis. The letter was signed by 45 HIV and global health organizations and experts.Read more
At a June UNGA meeting, Russia refused to support a consensus political declaration on ending the HIV/AIDS epidemic. What does this mean for the future of HIV/AIDS and international politics?
Read in the Washington Post
Our partners at Fundación Huésped in Argentina describe how they use the HIVPL to monitor whether countries are delivering on their policy commitments.Read more
The American Academy of HIV Medicine featured the HIVPL’s 2020 Global HIV Policy Report in a special issue of its magazine.Read more
The Global AIDS Strategy 2021-2026 sets an ambitious new set of targets, the 10-10-10 targets, calling on countries to repeal punitive laws/policies that target key populations and to implement right-supportive laws/policies that combat stigma, discrimination, and gender-based violence.
These targets will not be achieved without transparency, evidence, and accountability—transparency around the laws/policies that countries have in place, evidence to show why policy change is necessary and beneficial, and advocacy to hold governments accountable for acting on the commitments they made at the 2021 UN High-Level Meeting on HIV/AIDS and achieving the 10-10-10 targets.Read more
The science of HIV has never been better, but policy too often gets in the way of a robust HIV response. The HIV Policy Lab is a comprehensive database to monitor, track, and compare national HIV policies across countries. The HIV Policy Lab data and visualization tools examine whether science-based policies have been implemented at the national level in 194 countries. This video provides an overview of the HIV Policy Lab and features leaders in the fight against HIV discussing how it can be used.
On World AIDS Day last month, a breakthrough was announced for children with HIV in low-income countries. The integrase inhibitor dolutegravir, an antiretroviral medicine recommended for first-line treatment, is being manufactured in a 10- milligram formulation that can be given easily to infants weighing less than 20 kilograms. It dissolves in liquid and tastes like strawberries, and the price negotiated with generic drug companies Viatris and Macleods Pharmaceuticals is competitive. Following this announcement, the Global Fund to Fight AIDS, Tuberculosis and Malaria; the United States President's Emergency Plan...Read more
The state of the science around ending HIV has never been better, but slow translation of scientific advances into laws and policies is a major barrier to progress in the fight against HIV. Laws and policies drive who has access to the benefits of science, how people living with and affected by HIV are treated, how health systems are structured, and how officials engage with communities. This report presents the state of HIV policy in countries around the world in 2020. Drawing on data from the HIV Policy Lab, it tracks which countries have adopted 33 key HIV-related laws and policies recommended by UNAIDS and WHO and which have...Read more
Law and policy differences help explain why, as HIV-related science has advanced swiftly, some countries have realised remarkable progress on AIDS while others see expanding epidemics. We describe the structure and findings of a new dataset and research platform, the HIV Policy Lab, which fills an important knowledge gap by measuring the HIV-related policy environment across 33 indicators and 194 countries over time, with online access and visualisation. Cross-national indicators can be critical tools in international governance-building social power to monitor state behaviour with the potential to change policy and improve domestic...Read more